These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32122381)

  • 21. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
    Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ preservation following short-course radiotherapy for rectal cancer.
    Nilsson PJ; Ahlberg M; Kordnejad S; Holm T; Martling A
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34686879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
    Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
    World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial.
    Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R
    Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
    Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer.
    Wang S; Wen F; Zhang P; Wang X; Li Q
    Radiat Oncol; 2019 Jun; 14(1):113. PubMed ID: 31234886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment.
    Aker M; Boone D; Chandramohan A; Sizer B; Motson R; Arulampalam T
    Abdom Radiol (NY); 2018 Dec; 43(12):3213-3219. PubMed ID: 29767284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of MRI in Restaging Locally Advanced Rectal Cancer After Preoperative Chemoradiation.
    van den Broek JJ; van der Wolf FS; Lahaye MJ; Heijnen LA; Meischl C; Heitbrink MA; Schreurs WH
    Dis Colon Rectum; 2017 Mar; 60(3):274-283. PubMed ID: 28177989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.
    Hodges N; Battersby N; Rao S; Brown G;
    Ann Surg Oncol; 2023 Aug; 30(8):4729-4735. PubMed ID: 35771366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist's expert review.
    Valentini V; Glimelius B; Haustermans K; Marijnen CA; Rödel C; Gambacorta MA; Boelens PG; Aristei C; van de Velde CJ
    Radiother Oncol; 2014 Jan; 110(1):195-8. PubMed ID: 24286634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI?
    Heijnen LA; Lambregts DM; Lahaye MJ; Martens MH; van Nijnatten TJ; Rao SX; Riedl RG; Buijsen J; Maas M; Beets GL; Beets-Tan RG
    Abdom Radiol (NY); 2016 Jul; 41(7):1245-52. PubMed ID: 26814499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography.
    Siegel R; Dresel S; Koswig S; Gebauer B; Hunerbein M; Schneider W; Schlag PM
    Onkologie; 2008 Apr; 31(4):166-72. PubMed ID: 18418017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution.
    Roy A; Mahasittiwat P; Weiner AA; Hunt SR; Mutch MG; Birnbaum EH; Kodner IJ; Read TE; Fleshman JW; Olsen JR; Myerson RJ; Parikh PJ
    Pract Radiat Oncol; 2017; 7(1):e51-e58. PubMed ID: 27720702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
    Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?
    van der Sande ME; Beets GL; Hupkens BJ; Breukink SO; Melenhorst J; Bakers FC; Lambregts DM; Grabsch HI; Beets-Tan RG; Maas M
    Eur J Surg Oncol; 2019 Jun; 45(6):1011-1017. PubMed ID: 30528891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 40. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.